- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTCBB: MFLU), has implemented new initiatives in order to better meet the needs of the growing biotechnology, pharmaceutical, chemical, cosmetics/personal care and food industries beyond the boundaries of North America, and to satisfy the increasing global demand for the company's innovative Microfluidizer® high shear fluid processors.
Microfluidics has maintained a presence in Europe, the Middle East and Africa (EMEA) since the mid-90's, through in-country sales representatives managed from a central sales office in Germany. As part of the first phase of its global distribution expansion plans, the company is now increasing that presence with new sales representatives and partnerships in France, Jordan, Kazakhstan, Portugal, Russia, Switzerland and Ukraine.
"We see tremendous opportunities for short- and long-term growth in all industries we currently serve throughout EMEA, as new applications requiring high quality and stable particle size reduction show up every day" said Xavier Leroy, Microfluidics' Vice President of Sales for Europe, Middle East and Africa. "By escalating our sales and service presence in these regions, we will be better equipped to meet the ever-increasing demand for our Microfluidizer processors and to help our customers in these countries achieve success with their own products and applications."
Microfluidics has amplified its sales force in EMEA with the addition of sales and service professionals who are not only knowledgeable about current market segments' needs and trends, but who also have a complete understanding of the cultures, economies and languages in the countries that they serve. Additionally, Microfluidics runs a testing lab at its EMEA sales office in Lampertheim, Germany where prospects from throughout the region can determine how a Microfluidizer processor would address their formulation challenges.
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. Microfluidics is a leader in innovative technology and comprehensive solutions for formulations requiring repeatability and for the production of uniformly distributed nanoparticles.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the biotechnology, pharmaceutical, chemical, cosmetics/personal care and food industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, email or contact Microfluidics at 800.370.5452 for application information.
For more information, please click here
Gray & Rice Public Relations
617-367-0100 ext. 127
Microfluidics International Corporation
617-969-5452 ext. 245
Chief Financial Officer
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
IU chemists craft molecule that self-assembles into flower-shaped crystalline patterns:'Tricarb' research laid foundation for university's new $1.2 million materials science grant from National Science Foundation December 1st, 2015
Monitoring critical blood levels in real time in the ICU: EPFL has developed a miniaturized microfluidic device that will allow medical staff to monitor in real time levels of glucose, lactate a.s.o. and react more quickly October 22nd, 2015
Chip-based technology enables reliable direct detection of Ebola virus: Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA September 26th, 2015
New EU project designed to link diagnosis and treatment of diseases over the long term: Joint research project aims at the improvement of companion diagnostics and therapy of tumor diseases November 23rd, 2015
FEI and ICON Analytical Demonstrate the Power of TEM for Materials and Life Sciences Research: FEI’s Talos scanning transmission electron microscope will be available for demos and workshops at the Indian Institute of Science from 23 November to 15 December 2015 November 17th, 2015